| Financial Year |
March 31 2023 |
| Monetary Funds |
218,360,173.39 |
| Held-for-trading Financial Assets |
458,727.81 |
| Notes Receivable |
176,423,053.51 |
| Accounts Receivable |
1,026,741,844.03 |
| Advances to Suppliers |
75,504,213.78 |
| Other Receivables |
168,593,368.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
694,779,073.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,586,833.79 |
| Total Current Assets |
2,480,234,499.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,500,000.00 |
| Long-term Equity Investment |
104,381,971.38 |
| Investment Properties |
-- |
| Fixed Assetes |
978,848,637.69 |
| Under-construction Projects |
37,169,424.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,949,233.75 |
| R&D expenses |
23,326,198.64 |
| Goodwill |
22,813,090.96 |
| Long-Term Deferred and Prepaid Expenses |
1,534,457.32 |
| Deferred Income Tax Assets |
88,464,376.08 |
| Other Non-Current Assets |
8,388,514.37 |
| Sub-Total of Non-Current Assets |
1,719,364,561.50 |
| Total Assets |
4,199,599,060.88 |
| Short-Term Loans |
378,694,471.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
288,706,475.51 |
| Accounts Payable |
919,175,399.50 |
| Accounts Received In Advance |
2,802,161.07 |
| Employee Compensation Payable |
18,429,592.54 |
| Taxes Payable |
18,178,477.27 |
| Interest Payable |
1,828,878.35 |
| Dividend Payable |
-- |
| Other payables |
197,204,256.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,756,495.30 |
| Other Current Liabilities |
16,832,826.33 |
| Sub-Total of Current Liabilities |
2,024,057,789.78 |
| Long-term Loans |
175,716,067.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
568,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,170,098.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
898,749,724.10 |
| Total Liabilities |
2,922,807,513.88 |
| Paid-In Capital(Or Share Stock) |
725,255,525.00 |
| Capital Surplus |
744,349,507.29 |
| Surplus Reserve |
48,344,204.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-276,635,334.39 |
| Minority Stockholder's Interest |
32,185,754.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,244,605,792.81 |
| Owner's Equity（Stockholder's Equity） |
1,276,791,547.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,199,599,060.88 |
